Straumann Holding AG

QS51

Company Profile

  • Business description

    Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

  • Contact

    Peter Merian-Weg 12
    Basel4002
    CHE

    T: +41 619651111

    E: investor.relations@straumann.com

    https://www.straumann-group.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2025

    Employees

    11,815

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,624.906.60-0.08%
CAC 407,788.1038.69-0.49%
DAX 4024,038.19188.30-0.78%
Dow JONES (US)42,098.70244.95-0.58%
FTSE 1008,726.0152.04-0.59%
HKSE23,258.31123.68-0.53%
NASDAQ19,100.9498.22-0.51%
Nikkei 22537,722.401.71-0.00%
NZX 50 Index12,362.26220.07-1.75%
S&P 5005,888.5532.99-0.56%
S&P/ASX 2008,396.9010.70-0.13%
SSE Composite Index3,339.930.76-0.02%

Market Movers